| abstract |
The present invention provides peptides, compositions, and methods for treating digestive disorders. The present invention uses peptides and other agents that activate guanylate cyclase C (GC-C) receptor, including but not limited to irritable bowel syndrome (IBS), gastrointestinal motility disorders, Functional gastrointestinal tract disorder, gastroesophageal reflux disease (GERD), duodenal gastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia, visceral pain, gastric insufficiency, chronic pseudo intestinal obstruction ( Or pseudocolon obstruction), disorders and conditions associated with constipation, and other conditions and disorders described herein, peptides, compositions, and related methods for treating digestive diseases and conditions It is characterized by. [Selection figure] None |